Regenxbio said Thursday that its experimental gene therapy for Duchenne muscular dystrophy produced...
Regenxbio says Duchenne gene therapy succeeded in clinical trial, paving way for FDA submission
Regenxbio said Thursday that its experimental gene therapy for Duchenne muscular dystrophy produced sufficiently high levels of a miniaturized muscle...
Author: statnews.com
Read Original Article